CR483 : Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with TNM data, replaced by CR483a
|
Microarray Panel | Cervical cancer tissue microarray, containing 40 cases of cervix tumor with 8 normal tissues from autopsy, single core per case | |
Cores | 48 | |
Cases | 48 | |
Row number | 6 | |
Column number | 8 | |
Core Diameter (mm) | 1.5 | |
Thickness (µm) | 5 | |
Quality Control | Anti-Actin confirmed | |
Tissue Array Type | FFPE | |
Species | Human | |
Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | |
Notes | 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours. In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos. | No. | Age | Sex | Organ/Anatomic Site | Pathology diagnosis | TNM | Grade | Stage | Type | Image |
---|
1 | 32 | F | Cervix | Squamous cell carcinoma | 1 | malignant | ||||
2 | 45 | F | Cervix | Squamous cell carcinoma | 1 | malignant | ||||
3 | 53 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
4 | 35 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
5 | 43 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
6 | 52 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
7 | 37 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
8 | 74 | F | Cervix | Squamous cell carcinoma | 1 -- 2 | malignant | ||||
9 | 38 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
10 | 33 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
11 | 55 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
12 | 42 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
13 | 55 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
14 | 37 | F | Cervix | Squamous cell carcinoma | 2 -- 3 | malignant | ||||
15 | 28 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
16 | 58 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
17 | 36 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
18 | 41 | F | Cervix | Squamous cell carcinoma | 1 -- 2 | malignant | ||||
19 | 48 | F | Cervix | Squamous cell carcinoma | 1 -- 2 | malignant | ||||
20 | 43 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
21 | 41 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
22 | 50 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
23 | 39 | F | Cervix | Squamous cell carcinoma | 2 | malignant | ||||
24 | 53 | F | Cervix | Squamous cell carcinoma | 3 | malignant | ||||
25 | 47 | F | Cervix | Squamous cell carcinoma | 2 -- 3 | malignant | ||||
26 | 42 | F | Cervix | Squamous cell carcinoma | 3 | malignant | ||||
27 | 55 | F | Cervix | Squamous cell carcinoma | 3 | malignant | ||||
28 | 39 | F | Cervix | Squamous cell carcinoma | 3 | malignant | ||||
29 | 51 | F | Cervix | Endocervical type adenocarcinoma (sparse) | 1 | malignant | ||||
30 | 52 | F | Cervix | Endocervical type adenocarcinoma | 2 | malignant | ||||
31 | 72 | F | Cervix | Endocervical type adenocarcinoma | 2 | malignant | ||||
32 | 40 | F | Cervix | Intestinal type adenocarcinoma | - | malignant | ||||
33 | 34 | F | Cervix | Intestinal type adenocarcinoma | - | malignant | ||||
34 | 72 | F | Cervix | Endometrioid adenocarcinoma | - | malignant | ||||
35 | 32 | F | Cervix | Endometrioid adenocarcinoma | - | malignant | ||||
36 | 44 | F | Cervix | Serous papillary carcinoma | - | malignant | ||||
37 | 43 | F | Cervix | Adenocarcinoma | 2 | malignant | ||||
38 | 52 | F | Cervix | Adenocarcinoma | 2 | malignant | ||||
39 | 56 | F | Cervix | Adenocarcinoma | 1 | malignant | ||||
40 | 51 | F | Cervix | Adenocarcinoma | 2 | malignant | ||||
41 | 21 | F | Cervix | Normal cervical canals tissue | - | normal | ||||
42 | 21 | F | Cervix | Normal cervical tissue (fibrous tissue and blood vessel) | - | normal | ||||
43 | 15 | F | Cervix | Normal cervical tissue (chronic inflammation of cervix) | - | normal | ||||
44 | 21 | F | Cervix | Normal cervical tissue | - | normal | ||||
45 | 41 | F | Cervix | Normal cervical tissue (fibrous tissue and blood vessel) | - | normal | ||||
46 | 40 | F | Cervix | Normal cervical tissue | - | normal | ||||
47 | 21 | F | Cervix | Normal cervical tissue | - | normal | ||||
48 | 21 | F | Cervix | Normal cervical tissue (fibrous tissue and blood vessel) | - | normal |
Find overlapping cases with this tissue array:
- Product Code: CR483
- Availability: Out Of Stock